CIK 0001023024
- Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 582301143
- Phone
- +1 609-759-1810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- 4 Open-market buy SVP - CORP. DEV. & STRATEGY bought 10,000 shares at an average $27.51 ($275,087)
- 4 Grant or award Director acquired 13,346 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy HEAD OF R&D, COO-NOVITIUM OPS bought 10,000 shares at $27.65 ($276,503)
- 4 Shares withheld for taxes HEAD OF RARE DISEASE gave up 1,184 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, GENERICS gave up 1,167 shares (to pay taxes)
- 5 Insider Annual Insider Trading Report
- 4 Open-market buy Director bought 1,072 shares at $46.47 ($49,820)
- 4 Open-market buy Director bought 3,000 shares at $42.26 ($126,794)
- 4 Open-market buy Director bought 2,500 shares at $39.38 ($98,450)
- 4 Grant or award HEAD OF R&D, COO-NOVITIUM OPS acquired 1,346,080 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award SVP - CORP. DEV. & STRATEGY acquired 383,226 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes PRESIDENT & CEO gave up 2,577 shares (to pay taxes)
- 4 Shares withheld for taxes SVP OPS & PROD DEV gave up 1,878 shares (to pay taxes)
- 4 Shares withheld for taxes SENIOR VICE PRESIDENT AND CFO gave up 3,042 shares (to pay taxes)
- 4 Shares withheld for taxes SVP OPS & PROD DEV gave up 337 shares (to pay taxes)
- 4 Shares withheld for taxes SENIOR VICE PRESIDENT AND CFO gave up 612 shares (to pay taxes)
- 4 Shares withheld for taxes SVP OPS & PROD DEV gave up 802 shares (to pay taxes)
Page 17 of 42 · 835 filings